Ben Teply, MD

  • 3537 Citations
  • 13 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients

Muniyan, S., Xi, L., Datta, K., Das, A., Teply, B. A., Batra, S. K. & Kukreja, R. C., Aug 2020, In : Biochimica et Biophysica Acta - Reviews on Cancer. 1874, 1, 188383.

Research output: Contribution to journalReview article

2017

Treatment strategies for DNA repair-deficient prostate cancer

Teply, B. A. & Antonarakis, E. S., Aug 3 2017, In : Expert Review of Clinical Pharmacology. 10, 8, p. 889-898 10 p.

Research output: Contribution to journalReview article

14 Scopus citations
2016

Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer

Teply, B. A. & Antonarakis, E. S., Jun 1 2016, In : Current Opinion in Endocrinology, Diabetes and Obesity. 23, 3, p. 279-290 12 p.

Research output: Contribution to journalReview article

8 Scopus citations
2014

Identification and management of toxicities from immune checkpoint-blocking drugs

Teply, B. A. & Lipson, E. J., Nov 1 2014, In : Oncology (Williston Park, N.Y.). 28, p. 30-38 9 p.

Research output: Contribution to journalReview article

44 Scopus citations

Systemic therapy for bladder cancer - a medical oncologist's perspective

Teply, B. A. & Kim, J. J., 2014, In : Journal of Solid Tumors. 4, 2, p. 25-35 11 p.

Research output: Contribution to journalReview article

14 Scopus citations
2006

Nanoparticle-aptamer bioconjugates for targeted antineoplastic drug delivery

Teply, B. A., Rocha, F. G., Levy-Nissenbaum, E., Langer, R. & Farokhzad, O. C., 2006, In : American Journal of Drug Delivery. 4, 3, p. 123-130 8 p.

Research output: Contribution to journalReview article

5 Scopus citations